Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 6001
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 80nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 94nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 143nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 159nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 229nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 265nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 280nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 283nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 304nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 385nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 410nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 780nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 920nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.22E+3nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.23E+3nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.50E+3nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.74E+3nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.94E+3nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 3.75E+3nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 4.40E+3nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 5.17E+3nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 8.79E+3nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.09E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.16E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.24E+4nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.53E+4nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 2.11E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 2.37E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 3.03E+4nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 5.39E+4nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 5.57E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 5.85E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Human)
University of Utah Research Foundation
US Patent
University of Utah Research Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
